Publication | Open Access

Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study

OncologyGastrointestinal OncologyMedicineNeuropathic PainColorectal CancerPharmacotherapySevere Peripheral NeuropathyPharmacologyCancer ResearchGemcad Group StudyOxaliplatin-based Adjuvant Chemotherapy